NEW YORK (360Dx) – French pharmaceutical firm Pierre Fabre today announced it and Roche have extended a companion diagnostic agreement for Pierre Fabre's oncology drug candidate.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.